** Shares of telehealth company Doximity <DOCS.N> up 8.8% at $50.47

** Raymond James upgrades to "strong buy" from "outperform" rating; PT at $65

** Brokerage sees potential from AI monetization and possible shifts toward direct-to-consumer for healthcare providers, which could support above-market growth

** Sees long-term growth visibility and durability continues to improve

** 11 of 21 brokerages rate the stock "buy" or higher, 10 "hold"; their median PT is $65 - data compiled by LSEG

** As of last close, stock down ~13% YTD

(Reporting by Sanskriti Shekhar in Bengaluru)

((Sanskriti.Shekhar@thomsonreuters.com))